Atea Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2022
Total Assets: $666.7M
Liabilities Breakdown FY2022
Total Liabilities: $26.1M
Asset Breakdown
Total Assets: $666.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $188.5M | 28.3% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $1.7M | 0.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $476.5M | 71.5% |
Liabilities Breakdown
Total Liabilities: $26.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.6M | 9.8% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $23.6M | 90.2% |